
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.030 | 4.340 | 2.310 |
Shares | 97.960 | 97.960 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.708 | 26.551 |
Price to Book | 3.612 | 5.598 |
Price to Sales | 3.237 | 4.956 |
Price to Cash Flow | 17.304 | 16.333 |
Dividend Yield | 0.830 | 0.879 |
5 Years Earnings Growth | 10.736 | 12.388 |
Name | Net % | Category Average |
---|---|---|
Technology | 51.480 | 64.743 |
Industrials | 25.890 | 7.627 |
Healthcare | 12.500 | 4.607 |
Consumer Cyclical | 5.990 | 8.341 |
Communication Services | 4.140 | 13.957 |
Number of long holdings: 67
Number of short holdings: 16
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA | US67066G1040 | 7.65 | 167.02 | -2.70% | |
Amazon.com | US0231351067 | 5.58 | 232.33 | -1.42% | |
Keyence | JP3236200006 | 4.14 | 56,690.0 | +0.39% | |
Intuitive Surgical | US46120E6023 | 3.87 | 466.86 | +2.71% | |
Cadence Design | US1273871087 | 3.80 | 351.01 | +0.48% | |
Siemens AG | DE0007236101 | 3.22 | 226.00 | -1.76% | |
Autodesk | US0527691069 | 3.15 | 326.37 | +2.01% | |
Schneider Electric | FR0000121972 | 3.13 | 218.30 | +0.48% | |
Alphabet C | US02079K1079 | 3.04 | 235.17 | +1.08% | |
Daifuku Co Ltd | JP3497400006 | 3.03 | 4,785.0 | +0.93% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global SmartBeta Equity ZI Capitalu | 2.16B | 7.88 | 15.01 | 10.50 | ||
AXA Framlington Glbl I Cap USD | 596.69M | 2.91 | 12.19 | 8.57 | ||
LU1684370213 | 545.93M | 10.46 | 17.01 | - | ||
LU1694771590 | 545.93M | 10.06 | 16.14 | - | ||
LU1042830981 | 370.98M | 3.86 | -7.52 | 2.32 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review